Page last updated: 2024-10-22

aminoglutethimide and Polycystic Ovary Syndrome

aminoglutethimide has been researched along with Polycystic Ovary Syndrome in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, E1

Other Studies

1 other study available for aminoglutethimide and Polycystic Ovary Syndrome

ArticleYear
Prevention of cystic ovary induction in rabbits by aminoglutethimide.
    Acta endocrinologica, 1980, Volume: 94, Issue:2

    Topics: 3-Hydroxysteroid Dehydrogenases; Aminoglutethimide; Animals; Chorionic Gonadotropin; Female; Gonadot

1980